The Central Illinois Hematology Oncology Conference is an accredited continuous education to improve the care of cancer patients by educating cancer care providers about precision-guided management in hematology and oncology.
The Best of Hematology and Breast Cancer 2025 conference in Coeur d'Alene is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer.
The Best of Hematology and Breast Cancer 2025 conference in Boise is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer.
This accredited continuing education activity “2024 Seattle Cellular Therapy Summit: Updates & Focus on Accessibility ”, is recorded from the live conference held from 8/16/2024 to 8/17/2024.
The Best of Hematology and Breast Cancer 2025 conference in Des Moines is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer.
The Best of Hematology and Breast Cancer 2025 conference in Augusta is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer.
The Best of Hematology 2025 conference in Albuquerque is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology.
The Best of Hematology and Breast Cancer 2025 conference in Houston is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer.
The Best of Hematology and Breast Cancer 2025 conference in Portland is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer.
The Best of Hematology and Breast Cancer 2025, Phoenix conference in Scottsdale, AZ is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer.